DALLAS Allarae Health Care, a Dallas-based medical technology company, and Lobeck Medical, a Swiss-based home-test kit manufacturer, earlier this month agreed upon a joint venture that is expected to showcase telemedicine-friendly products in the U.S. as early as this fall.
Lobeck Medical fields several products from blood glucose meters to diagnostic test kits for pregnancy, ovulation, female menopause and colon cancer.
Together the two companies will launch several new products in the field of early cancer detection such as breast cancer monitoring, strep throat detection, prostate PSA and flu virus screening. FDA and CE approval has already been obtained for several tests which are ready for immediate global sale under the worldwide brand name “MediSmart of Switzerland,” the companies stated.
Under the main provisions of the new agreement, Allarae will make available a comprehensive software system for test result tracking and monitoring under the “MediSmart of Switzerland” brand. The software will integrate all the test kits and blood glucose meters manufactured by Lobeck into a central data vault and tracking network, thereby creating a unique, first-to-market international offering, the companies stated. These new products, among others, will be presented at the worlds leading medical trade fair MEDICA in November 2008 in Dusseldorf/Germany, which is expected to be a coming out party, of sorts, for consumer-friendly telemedicine solutions.